Advanced MRI imaging for pulmonary fibrosis
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests whether advanced MRI scans can better detect and track lung scarring in people with certain types of pulmonary fibrosis. It may help doctors understand how well your treatment is working, without extra radiation from CT scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old and have been diagnosed with a type of lung scarring called pulmonary fibrosis, caused by conditions like chronic hypersensitivity pneumonitis, connective tissue disease, or undifferentiated ILD.
- You have been on a stable dose of immunosuppressive medications (such as prednisone, mycophenolate, or rituximab) for at least 3 months.
- Your lung function tests show your FVC is at least 45% of predicted and your DLCO is at least 25% of predicted.
- You have not taken any anti-fibrotic drugs (like pirfenidone or nintedanib) in the past, and you have not smoked in the last 6 months.
- You are able to have an MRI with contrast (no metal implants, no severe kidney disease, and no allergy to the contrast dye).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced imaging to see how immunosuppressive medications (like mycophenolate or prednisone) affect lung scarring in patients with certain types of lung fibrosis. You would have imaging scans and breathing tests to track changes over time.
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
This study tests a special PET scan that uses a new tracer to help see fibrosis (scarring) in the body. It may help doctors better understand and manage conditions like lung or liver fibrosis.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This trial uses an advanced MRI technique with a special gas (hyperpolarized xenon-129) to look at lung function in people with idiopathic pulmonary fibrosis (IPF). It may help doctors better understand how the disease affects your lungs and could lead to improved care.
This study uses special MRI scans with a gas you breathe in (xenon) and CT scans to see how well anti-fibrotic treatment is working in people with lung scarring (fibrotic interstitial lung disease). If you have this condition and are planning to start or continue treatment, this study could help doctors understand if the treatment is helping your lungs.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.